Cointime

  • Новости
  • заголовки
  • Кавычки
  • Столбец
  • Активность
  • Bitcoin $61,597.09 +2.43%
  • Ethereum $1,694.35 +4.47%
  • BNB $560.52 +1.29%
  • Optimism $0.10 +4.28%
  • Arbitrum $0.08 -0.58%
  • Solana $80.66 +3.79%
  • Polygon $0.22 +2.77%
  • Cosmos $1.54 -0.72%
  • Avalanche $6.75 +0.19%
  • Bitcoin $61,597.09 +2.43%
  • Ethereum $1,694.35 +4.47%
  • BNB $560.52 +1.29%
  • Optimism $0.10 +4.28%
  • Arbitrum $0.08 -0.58%
  • Solana $80.66 +3.79%
  • Polygon $0.22 +2.77%
  • Cosmos $1.54 -0.72%
  • Avalanche $6.75 +0.19%
Home / Neumora Therapeutics / investors

Neumora Therapeutics

company

Investors

Number of Lead Investors
Number of Investors
3
17
Neumora Therapeutics is funded by 17 investors. Mubadala Capital Ventures and ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Mubadala Capital Ventures Yes Series B
ARCH Venture Partners - Series B
Abu Dhabi Growth Fund - Series B
Altitude Life Science Ventures - Series B
Amgen - Series B
EXOR N.V. - Series B
F-Prime Capital - Series B
Invus - Series B
Newpath Management - Series B
Polaris Partners - Series B
Alexandria Venture Investments - Series A
Catalio Capital Management - Series A
Logos Capital - Series A
re.Mind Capital - Series A
SoftBank Vision Fund - Series A
Surveyor Capital - Series A
Waycross Ventures - Series A

Contact

Watertown,Massachusetts,United States
Cointime
Содержание
  • Новости
  • венчурный капитал
  • Отраслевые исследования
  • наука и технология
  • Активность
компания
  • о нас
  • Рекламное сотрудничество
  • Отказ от ответственности
  • © 2023 Cointime. все права защищены
  • политика конфиденциальности
  • Условия использования